BCLI: Brainstorm Cell Therapeutics Inc. Stocks News on July 26, 2024

BCLI

CNW Group

2 days ago

BCLI Update - Progress Supports Our 10x Plus Value Range Potential

BCLI

Zacks Small Cap Research

16 days ago

BCLI: Preparing to Initiate Phase 3b Trial of NurOwn™ Before End of 2024…

BrainStorm Cell Therapeutics to Provide Corporate Mid-Year Update on NurOwn Program

BCLI

PR Newswire

a month ago

BrainStorm Cell Therapeutics to Provide Corporate Mid-Year Update on NurOwn Program

BCLI

MT Newswires

a month ago

Brainstorm Cell Therapeutics Prices Registered Direct Offering, Concurrent Private Placement

BrainStorm Cell Therapeutics Announces Pricing of $4.0 Million Registered Direct Offering

BCLI

PR Newswire

a month ago

BrainStorm Cell Therapeutics Announces Pricing of $4.0 Million Registered Direct Offering

BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn® Clinical Trial

BCLI

PR Newswire

a month ago

BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn® Clinical Trial

BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer

BCLI

PR Newswire

a month ago

BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer

BCLI

PR Newswire

a month ago

BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation

Italian energy company targets Britain for fleet of 20 mini-nukes

BCLI

The Telegraph

2 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

BCLI

Motley Fool

2 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

BCLI

AFP

2 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

BCLI

Simply Wall St.

2 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

BCLI

Simply Wall St.

2 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

BCLI

Simply Wall St.

2 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

BCLI

Simply Wall St.

2 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

BCLI

Motley Fool

2 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

BCLI

Motley Fool

2 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BCLI

Motley Fool

2 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BCLI

Motley Fool

2 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

BCLI

AFP

2 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

BCLI

Motley Fool

2 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

BCLI

GuruFocus.com

2 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

BCLI

GuruFocus.com

2 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

BCLI

Simply Wall St.

2 months ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn

BCLI

PR Newswire

2 months ago

BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn

BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

BCLI

PR Newswire

2 months ago

BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn

BCLI

PR Newswire

3 months ago

BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn

BCLI

Zacks Small Cap Research

4 months ago

BCLI: Receives SPA Agreement from FDA on Design of Phase 3b Trial of NurOwn™…

BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule

BCLI

PR Newswire

4 months ago

BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS

BCLI

PR Newswire

4 months ago

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

BCLI

PR Newswire

4 months ago

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

BrainStorm Cell Therapeutics to Provide Update on NurOwn Program

BCLI

PR Newswire

4 months ago

BrainStorm Cell Therapeutics to Provide Update on NurOwn Program

BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

BCLI

PR Newswire

4 months ago

BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

BCLI

Zacks Small Cap Research

5 months ago

BCLI: Unveils Plans for Phase 3b Trial of NurOwn® in ALS…

BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference

BCLI

PR Newswire

5 months ago

BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference

BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS

BCLI

PR Newswire

5 months ago

BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS

BrainStorm Cell Therapeutics to Present at European Life Sciences CEO Forum

BCLI

PR Newswire

5 months ago

BrainStorm Cell Therapeutics to Present at European Life Sciences CEO Forum

Nutriband CEO Publishes Letter to Shareholders

BCLI

ACCESSWIRE

6 months ago

Nutriband CEO Publishes Letter to Shareholders

Getaround Secures $20 Million in Financing, Following Strong Q3 2023 Results

BCLI

Business Wire

6 months ago

Getaround Secures $20 Million in Financing, Following Strong Q3 2023 Results

Mullen Announces Bollinger Motors Receives Vehicle Orders for 40 B4, Class 4 EV Trucks; Valued at Approximately $6 Million

BCLI

GlobeNewswire

6 months ago

Mullen Announces Bollinger Motors Receives Vehicle Orders for 40 B4, Class 4 EV Trucks; Valued at Approximately $6 Million

Sidoti Events, LLC's Virtual January Micro-Cap Conference

BCLI

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

U.S. Global Investors Announces Share Buyback Numbers for December 2023; Provides an Update on Competitive Year-End Performance for Quant Gold ETF

BCLI

GlobeNewswire

6 months ago

U.S. Global Investors Announces Share Buyback Numbers for December 2023; Provides an Update on Competitive Year-End Performance for Quant Gold ETF

ECD Auto Design Expects Organic Revenue Growth of Over 50% in 2024 with Continued GAAP Profitability

BCLI

GlobeNewswire

6 months ago

ECD Auto Design Expects Organic Revenue Growth of Over 50% in 2024 with Continued GAAP Profitability

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

BCLI

Benzinga

7 months ago

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Harte Hanks Extends Line of Credit with Texas Capital Bank

BCLI

ACCESSWIRE

7 months ago

Harte Hanks Extends Line of Credit with Texas Capital Bank

Safe Harbor Financial Originates $9 Million First Lien Secured Loan for Major, MSO-Operated Cultivation Facility in Denver, Colorado

BCLI

GlobeNewswire

7 months ago

Safe Harbor Financial Originates $9 Million First Lien Secured Loan for Major, MSO-Operated Cultivation Facility in Denver, Colorado

$Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia$

BCLI

GlobeNewswire

7 months ago

Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

Bright Scholar Filed Annual Report on Form 20-F for Fiscal 2023

BCLI

PR Newswire

7 months ago

Bright Scholar Filed Annual Report on Form 20-F for Fiscal 2023

Expion360 Announces Financing Commitments of up to $22.5 Million

BCLI

ACCESSWIRE

7 months ago

Expion360 Announces Financing Commitments of up to $22.5 Million

Yoshitsu Co., Ltd Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

BCLI

GlobeNewswire

7 months ago

Yoshitsu Co., Ltd Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

OLD POINT FINANCIAL CORPORATION ANNOUNCES RETIREMENT OF DR. ARTHUR D. GREENE FROM BOARD OF DIRECTORS

BCLI

PR Newswire

7 months ago

OLD POINT FINANCIAL CORPORATION ANNOUNCES RETIREMENT OF DR. ARTHUR D. GREENE FROM BOARD OF DIRECTORS

BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments

BCLI

PR Newswire

7 months ago

BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments

Are Options Traders Betting on a Big Move in Airgain (AIRG) Stock?

BCLI

Zacks

7 months ago

Are Options Traders Betting on a Big Move in Airgain (AIRG) Stock?

BrainStorm Issues 2023 Letter to Shareholders

BCLI

PR Newswire

7 months ago

BrainStorm Issues 2023 Letter to Shareholders

BCLI

InvestorPlace

7 months ago

3 Growth Stocks That Can Double in 2024

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors

BCLI

PR Newswire

7 months ago

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors

Expion360 Enters Home Energy Storage Market with All-in-One and Scalable Lithium-ion Battery Solutions

BCLI

ACCESSWIRE

7 months ago

Expion360 Enters Home Energy Storage Market with All-in-One and Scalable Lithium-ion Battery Solutions

Good Times Restaurants Inc. (NASDAQ:GTIM) Q4 2023 Earnings Call Transcript

BCLI

Insider Monkey

7 months ago

Good Times Restaurants Inc. (NASDAQ:GTIM) Q4 2023 Earnings Call Transcript

Linkage Global Inc Announces Pricing of $6,000,000 Initial Public Offering

BCLI

GlobeNewswire

7 months ago

Linkage Global Inc Announces Pricing of $6,000,000 Initial Public Offering

enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium

BCLI

ACCESSWIRE

7 months ago

enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium

BCLI

Investing.com

7 months ago

Midday movers: Adobe, Moderna, and more

Mesa Air Group Announces Intent to File Form 12b-25 and Delay Its Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

BCLI

GlobeNewswire

7 months ago

Mesa Air Group Announces Intent to File Form 12b-25 and Delay Its Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

Gold Resource Corporation Reports High Grade Drill Results at the Don David Gold Mine

BCLI

Business Wire

7 months ago

Gold Resource Corporation Reports High Grade Drill Results at the Don David Gold Mine

BCLI

GlobeNewswire

8 months ago

Brad Jacobs to Enter Building Products Distribution Industry

BCLI

Zacks Small Cap Research

8 months ago

BCLI: FDA Meeting Provides Clear Path for Planned Phase 3b Trial of NurOwn

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

BCLI

PR Newswire

8 months ago

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

XPO's Brad Jacobs talks SilverSun acquisition, equity growth

BCLI

Yahoo Finance Video

8 months ago

XPO's Brad Jacobs talks SilverSun acquisition, equity growth

Precision Optics Enters into Production and Technology Licensing Agreement for Single-Use Cystoscopy Robotic Surgery Program

BCLI

PR Newswire

8 months ago

Precision Optics Enters into Production and Technology Licensing Agreement for Single-Use Cystoscopy Robotic Surgery Program

Shareholders Will Probably Hold Off On Increasing Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Compensation For The Time Being

BCLI

Simply Wall St.

8 months ago

Shareholders Will Probably Hold Off On Increasing Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Compensation For The Time Being

Under The Bonnet, Drilling Tools International's (NASDAQ:DTI) Returns Look Impressive

BCLI

Simply Wall St.

8 months ago

Under The Bonnet, Drilling Tools International's (NASDAQ:DTI) Returns Look Impressive

Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

BCLI

GlobeNewswire

8 months ago

Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Great Lakes Dredge & Dock to Present at Sidoti December Small Cap Virtual Conference on Wednesday, December 6, 2023

BCLI

GlobeNewswire

8 months ago

Great Lakes Dredge & Dock to Present at Sidoti December Small Cap Virtual Conference on Wednesday, December 6, 2023

3 Hot Penny Stocks to Buy in Q4 for Promising Potential

BCLI

InvestorPlace

8 months ago

3 Hot Penny Stocks to Buy in Q4 for Promising Potential

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS

BCLI

PR Newswire

8 months ago

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS

Garry Mauro Bought 9.9% More Shares In LifeVantage

BCLI

Simply Wall St.

8 months ago

Garry Mauro Bought 9.9% More Shares In LifeVantage

BrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia

BCLI

PR Newswire

8 months ago

BrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia

BCLI

Zacks Small Cap Research

8 months ago

BCLI: Phase 3b Trial Details to be Discussed with FDA…

BCLI

Insider Monkey

8 months ago

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript

BCLI

Business Wire

8 months ago

Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows

America's Biggest Wood Pellet Exporter Warns Its Future Is in Jeopardy; Stock Crashes

BCLI

The Wall Street Journal

9 months ago

America's Biggest Wood Pellet Exporter Warns Its Future Is in Jeopardy; Stock Crashes

BCLI

Business Wire

9 months ago

Quantum-Si Reports Third Quarter 2023 Financial Results

BCLI

ACCESSWIRE

9 months ago

Avino Reports Q3 2023 Financial Results

Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards

BCLI

Business Wire

9 months ago

Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards

BCLI

Associated Press Finance

9 months ago

FTC Solar: Q3 Earnings Snapshot

FTC Solar Announces Third Quarter 2023 Financial Results and Leadership Transition

BCLI

GlobeNewswire

9 months ago

FTC Solar Announces Third Quarter 2023 Financial Results and Leadership Transition

Abacus Life to Participate in the Stephens Investment Conference

BCLI

GlobeNewswire

9 months ago

Abacus Life to Participate in the Stephens Investment Conference

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting

BCLI

GlobeNewswire

9 months ago

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Latest Brainstorm Cell Therapeutics Inc. (BCLI) News on July 26, 2024

Share on Social Networks: